36,328 Shares in Select Medical Holdings Co. (NYSE:SEM) Bought by PharVision Advisers LLC

PharVision Advisers LLC bought a new position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 36,328 shares of the health services provider's stock, valued at approximately $685,000. Select Medical makes up about 0.6% of PharVision Advisers LLC's holdings, making the stock its 19th biggest holding.

Several other hedge funds have also recently modified their holdings of the company. Barclays PLC lifted its holdings in Select Medical by 396.0% during the third quarter. Barclays PLC now owns 192,357 shares of the health services provider's stock worth $6,707,000 after acquiring an additional 153,576 shares during the period. Inspire Investing LLC increased its position in shares of Select Medical by 78.6% during the 4th quarter. Inspire Investing LLC now owns 21,258 shares of the health services provider's stock valued at $401,000 after purchasing an additional 9,355 shares during the last quarter. CX Institutional raised its stake in shares of Select Medical by 8.9% during the 4th quarter. CX Institutional now owns 37,904 shares of the health services provider's stock worth $714,000 after purchasing an additional 3,083 shares during the period. Linden Thomas Advisory Services LLC boosted its holdings in shares of Select Medical by 16.1% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 25,576 shares of the health services provider's stock worth $482,000 after buying an additional 3,541 shares during the last quarter. Finally, KBC Group NV grew its position in Select Medical by 14.0% during the fourth quarter. KBC Group NV now owns 14,883 shares of the health services provider's stock valued at $281,000 after buying an additional 1,833 shares during the period. Institutional investors own 89.48% of the company's stock.

Select Medical Trading Down 0.8%

Shares of SEM stock traded down $0.11 on Monday, hitting $14.38. 1,298,322 shares of the company's stock traded hands, compared to its average volume of 902,729. The stock has a market capitalization of $1.85 billion, a price-to-earnings ratio of 8.72, a P/E/G ratio of 0.64 and a beta of 1.40. The company's fifty day simple moving average is $16.11 and its 200 day simple moving average is $19.62. Select Medical Holdings Co. has a one year low of $14.03 and a one year high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same period last year, the business posted $0.75 earnings per share. The firm's quarterly revenue was down 24.4% compared to the same quarter last year. Equities analysts forecast that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date is Thursday, May 15th. Select Medical's dividend payout ratio (DPR) is presently 18.66%.

Select Medical declared that its Board of Directors has initiated a share buyback plan on Thursday, May 1st that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to purchase up to 42.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on SEM. Wall Street Zen raised Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research report on Monday, February 24th. Royal Bank of Canada lowered their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. Finally, Mizuho started coverage on Select Medical in a report on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price objective for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $26.00.

Insider Transactions at Select Medical

In other Select Medical news, CEO David S. Chernow sold 225,000 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the sale, the chief executive officer now owns 714,516 shares in the company, valued at approximately $12,861,288. This trade represents a 23.95% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Parvinderjit S. Khanuja bought 21,000 shares of Select Medical stock in a transaction dated Monday, May 5th. The shares were acquired at an average cost of $15.02 per share, for a total transaction of $315,420.00. Following the completion of the purchase, the director now directly owns 65,089 shares of the company's stock, valued at approximately $977,636.78. This trade represents a 47.63% increase in their position. The disclosure for this purchase can be found here. Company insiders own 11.60% of the company's stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.